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Abstract
Pseudomonas aeruginosa is an important opportunistic pathogen causing chronic airway infections, especially in cystic
fibrosis (CF) patients. The majority of the CF patients acquire P. aeruginosa during early childhood, and most of them
develop chronic infections resulting in severe lung disease, which are rarely eradicated despite intensive antibiotic therapy.
Current knowledge indicates that three major adaptive strategies, biofilm development, phenotypic diversification, and
mutator phenotypes [driven by a defective mismatch repair system (MRS)], play important roles in P. aeruginosa chronic
infections, but the relationship between these strategies is still poorly understood. We have used the flow-cell biofilm model
system to investigate the impact of the mutS associated mutator phenotype on development, dynamics, diversification and
adaptation of P. aeruginosa biofilms. Through competition experiments we demonstrate for the first time that P. aeruginosa
MRS-deficient mutators had enhanced adaptability over wild-type strains when grown in structured biofilms but not as
planktonic cells. This advantage was associated with enhanced micro-colony development and increased rates of
phenotypic diversification, evidenced by biofilm architecture features and by a wider range and proportion of morphotypic
colony variants, respectively. Additionally, morphotypic variants generated in mutator biofilms showed increased
competitiveness, providing further evidence for mutator-driven adaptive evolution in the biofilm mode of growth. This
work helps to understand the basis for the specific high proportion and role of mutators in chronic infections, where P.
aeruginosa develops in biofilm communities.
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Introduction
Mutation rate is controlled by several genetic systems.
Particularly relevant is the mismatch repair system (MRS), which
monitors the fidelity of DNA replication and recombination by
repairing DNA polymerase errors and blocking recombination
events between divergent (homeologous) DNA sequences [1,2].
Consequently, defects in the MRS cause enhanced mutation rates
and increases in recombination of divergent sequences, resulting in
a phenotype known as the hypermutator or just mutator
phenotype [1,2]. Since mutation is the substrate for natural
selection, the potential role of mutator phenotypes in adaptive
evolution has attracted a huge biological and medical interest for
decades. Indeed, early in vitro experiments, using Escherichia coli as
model organism, indicated that the occurrence of mutators in
bacterial populations provide a higher probability of generating
advantageous mutations, allowing faster adaptation to new and/or
changing environments [3].
In recent years, Pseudomonas aeruginosa has been recognized as an
interesting model organism for investigations of the role of MRS in
bacterial adaptive strategies [4–13]. P. aeruginosa is an important
opportunistic pathogen causing chronic airway infections, espe-
cially in cystic fibrosis (CF) patients, but also in patients suffering
from other chronic lung pathologies such as chronic obstructive
pulmonary disease (COPD) or bronchiectasis [14–16]. The
majority of CF patients acquire P. aeruginosa during early
childhood, and most of them eventually develop a chronic
infection, which is rarely eradicated despite intensive antibiotic
therapy [14]. A striking feature of P. aeruginosa chronic infections is
the very high prevalence (30–60%) of mutator strains [4,17–20],
mainly due to alterations in the mutS or mutL genes, the main
components of the MRS [4,5]. In contrast, detection of mutators is
very infrequent in P. aeruginosa acute infections [21]. Moreover,
recent research suggests that mutators may contribute to P.
aeruginosa adaptation to the CF airways environment, since their
presence is found to be linked to the acquisition of beneficial
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mutations [10,22] such as those conferring antibiotic resistance
[4,5,17,20,23,24]. Nevertheless, the connection between mutator
phenotypes and other adaptive strategies involved in P. aeruginosa
chronic infections is still not clarified. P. aeruginosa most often
resides within the thick CF mucus as biofilm structures [25,26]
that consist of organized consortia of bacteria embedded in a self-
produced polymer matrix consisting of polysaccharide, protein
and DNA. Importantly, it has been shown that the biofilm lifestyle
provides P. aeruginosa with higher tolerance to antibiotics as well as
resistance to phagocytosis and other components of the body’s
defense system [25,26]. P. aeruginosa undergoes genetic diversifica-
tion in the CF airways based on mutagenic events, leading to the
emergence, selection and fixation of multiple phenotypic variants
particularly adapted to specific anatomic niches in the CF lung
[10,22,27]. Among them, mucoid, quorum-sensing deficient and
smooth or rough small colony variants are the most common, and
their emergence has been correlated with decreased lung function
and poor prognosis for the patient [28–30].
Flow-cell biofilms formed by P. aeruginosa have been studied
intensely in recent years [31,32]. From these studies, it has been
documented that biofilm formation is a complex multifactorial
process regulated by both genetic and environmental factors [33].
Recognized stages in biofilm formation include initial bacterial
attachment, micro-colony development, maturation of micro-
colonies into large 3D-structures, and dispersion of bacterial cells
from biofilms. Since mature micro-colonies constitute heteroge-
neous micro-environments, mainly defined by oxygen and nutrient
limitations [34], a biofilm is a spatially structured environment
[35], and adaptation to this environment may involve genetic
diversification [36]. In fact, previous works reveals that for a wide
range of bacterial species, biofilms grown in vitro generate extensive
genetic diversity leading to the emergence of different biofilm
adapted phenotypes [37–42]. Particularly, from P. aeruginosa
biofilms, a wide range of colony morphology variants have been
observed including small [43–46], rugous [44,46,47] and mucoid
colony variants [8,48], suggesting the existence of strong and
varied selective pressures driving fixation of different phenotypes,
similar to the diversification process observed in chronic CF
airway infections [22,27,49]. Furthermore, recent evidence
suggests that mutation may play a role in biofilm development
[50] and that biofilm-mediated diversity in P. aeruginosa is based on
intrinsically increased mutagenesis caused by endogenous oxida-
tive stress [51,52].
The parallel findings from CF airway samples and in vitro
biofilms suggest that three adaptive strategies may be important
for the development of P. aeruginosa chronic CF lung infections: (i)
biofilm development, (ii) phenotypic diversification, and (iii)
hypermutability. In order to understand better the connection
between these processes we used the flow-cell biofilm model
system to investigate the impact of the mutS mutator phenotype on
development, structure, dynamics, diversification and adaptation
of P. aeruginosa biofilms.
Results
Structural dynamics of biofilms formed by wild-type and
mutator strains of P. aeruginosa
Biofilm development of two P. aeruginosa strains, the reference
strain PAO1 [53] and the environmental strain Hex1T [54] as
well as their mutS isogenic mutants, PAOMS [55] and Hex1TMS
[6], respectively, was monitored in flow-cell systems and
characterized by scanning laser confocal microscopy (CLSM).
Cellular adhesion was examined for all strains by assessing the
number of cells adhering to the flow-cell glass cover slides after
medium flow was resumed. Both Hex1TMS and PAOMS mutS
strains showed comparable adherence [3.760.26104 cells/cm2
and 3.6626104 cells/cm2 (mean 6 SD), respectively] to the
Hex1T and PAO1 wild-type strains [3.961.36104 cells/cm2 and
5.362.46104 cells/cm2 (mean 6 SD), respectively], suggesting
that a high mutation rate does not affect the initial attachment of
cells, at least under the conditions assayed here.
Biofilm development was investigated by acquiring CLSM
micrographs at 15, 24, 48, 96 and 144 h and subjecting the digital
three-dimensional images to COMSTAT image analysis. At 15 h
after inoculation, the two wild-type strains formed small, ball-
shaped micro-colonies (Figure 1 A and K). In contrast, the
respective mutator strains showed significantly less organized
micro-colonies, in which singles cells could still be distinguished
(Figure 1 F and P). These differences were also documented from
the quantitative COMSTAT analysis, showing that at 15 h the
mutator strains displayed significantly lower biomass accumulation
and thickness but higher surface to volume ratios (Figure S1). After
this lag in biomass development both wild-type and mutator
strains showed a normal maturation pattern with micro-colony
differentiation leading to development of mushroom-shaped
multicellular structures reaching full maturation on day 6
(Figure 1).
However, the two mutator strains reproducibly developed into
micro-colony structures distinctly different from the wild-type
strains, as revealed by the microscopic analysis. In order to
quantitatively characterize the micro-colonies formed by each
strain, the diameters of single micro-colonies were measured from
24 randomly chosen CLSM micrographs of each strain at 24, 48,
96, and 144 h using LSM Image Browser software. As shown in
Figure 2, the diameter of the micro-colonies increased over time
for both wild-types and mutators (ANOVA with repeated
measures, P,0.05). After 24 h of growth the micro-colony
diameters were very similar in mutator and wild-type biofilms,
but during the next 24 h micro-colony sizes increased faster in the
mutator biofilms (Figure 2). Thus, at 48 h micro-colony diameters
were 62.462.5 mm (95% confidence interval 57.3-67.5) and
35.762.5 mm (95% confidence interval 30.7–40.8) for Hex1TMS
and Hex1T, respectively. These differences were maintained
during the following 96 and 144 h of growth (Figure 2 A).
Interestingly, at 48 h Hex1TMS biofilms showed a greater
variability in micro-colony diameters (intervals 41.9–115.4 mm)
with oversized micro-colonies, which resulted in a higher
heterogeneity in biofilm structure. Equivalent results were
obtained with the PAO1 strain (Figure 2 B), indicating that
mutator biofilms develop with accelerated growth compared to
their wild-type counterparts, reaching maturity states at earlier
time points.
Furthermore, in mutator biofilms central voids in micro-
colonies were frequently observed already after 96 h of incubation,
whereas in non-mutator biofilms these structures were hardly
detected during the 6 days of biofilm growth tested (Figure S2 A
and B). Previous reports have documented the presence of large
voids in micro-colonies after 7 days of growth [56], and it has been
proposed that a ‘‘threshold diameter’’ of approximately 80 mm is
required for the onset of the seeding dispersal from the interior of
the microcolonies [57]. Consistent with this, the stage where
mutators micro-colonies reached this threshold diameter
[71.563.4 and 84.363.1 mm micro-colony diameters (mean 6
SE) for Hex1TMS at 96 h and 144 h, respectively], was the same
at which the frequency of hollow micro-colonies was increased
(Figure S2 B), indicating that the greater rate of dispersal could be
associated with the accelerated development of mutator biofilms.
Mutators and Biofilm Development in P. aeruginosa
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Increased phenotypic diversification in mutator biofilms
Biofilms often develop into spatially and temporally heteroge-
neous 3D-structures [35], which may provide multiple ecological
niches selecting for phenotypically distinct subpopulations [58]. In
addition to niche-associated modifications in gene expression (cell
physiology), the acquisition of mutations and chromosomal
rearrangements are thought to play important roles in the
generation of biofilm-adapted phenotypes [35,51]. Consistently,
several reports have previously described that in vitro P. aeruginosa
biofilms undergo extensive genetic diversification
[30,44,46,47,51]. Moreover, inactivation of MRS was shown to
increase phenotypic diversity resulting from phase variation in
Neisseria meningitidis [59] and mutation-driven phenotypic switches
in P. aeruginosa [6-8], thus increasing adaptation and facilitating
niche expansion. Based on these antecedents, we examined the
impact of MRS deficiency on phenotypic diversification of P.
aeruginosa biofilms. For this purpose, 6-day-old biofilms of Hex1T,
Hex1TMS, PAO1 and PAOMS were harvested from flow-cells
and plated on LB-agar. After 48 h of incubation approximately
104 colonies from each strain were visually inspected for colony
morphology variation. As shown in Table 1, variation in colony
morphology was greatly increased in both Hex1TMS and
PAOMS mutator biofilms. Approximately 20-35% of the total
CFUs were different from the standard parental morphotype, and
at least 8 distinct morphotypes could be recognized. Among them,
flat colonies with translucent edges (T), wrinkled colonies (W) as
well as large (L) and smooth small (S) colony variants were the
most abundant types (Table 1, Figure 3). These morphotypes were
likely consequences of genetic changes, since reversion was not
observed after at least two passages on LB-agar plates. Morpho-
typical diversity was also observed in both non-mutator wild-type
strains, but to a much lower extent, as evidenced not only by the
smaller number of morphotypes detected, but also by their
significantly lower frequency (Table 1, Figure 4 A, Student t test
P,0.05).
Differences in morphotypical diversification between mutators
and non-mutators were mainly observed during biofilm growth,
since colony diversity for all strains was very low in the biofilm
inocula as well as in experiments of planktonic growth conducted
in homogeneous aerated liquid media (Figure 4 A and B).
Increasing diversity was also observed when biofilm effluents from
Hex1TMS were analyzed at 48, 96 and 144 h post-inoculation,
respectively (Figure 4 C). In fact, whereas effluents obtained from
the Hex1T non-mutator strain showed a poorly detectable
diversity throughout the entire time period of biofilm develop-
ment, a progressive morphological diversification was apparent
from mutator effluents reaching a maximum at 144 h (Figure 4 C).
It is important to note that the most abundant variants (T, S, W
and L) obtained from mutator biofilms were distinguishable from
their respective ancestors not only by their colony morphologies
but also by properties such as motility, exopolysacharide matrix
and iron uptake capability (Figure S3 and Table S1). This clearly
suggests that colony morphology variation is a useful indicator of
population diversification as was shown previously in several
publications by Rainey et al. [36,60] and Hansen et al. [42,61].
Although previous genetic studies have proposed possible
molecular bases underlying the emergence of P. aeruginosa
biofilm-related colony morphologies [46,62–64], mutations that
generate each colony type observed in this study remains to be
elucidated.
Competitive advantage of mutators in biofilm growth
The results presented above show that P. aeruginosa MRS-
deficient mutators exhibit greater micro-colony development
Figure 1. Biofilm formation by P. aeruginosa wild-type and mutator strains. The images shown are 3D-reconstructed images of biofilm
dynamics of Hex1T (A-E), Hex1TMS (F-J), PAO1 (K-O) and PAO1MS (P-T). The development of mutator biofilms was exhaustively studied in parallel to
wild-type biofilms. All strains were GFP-tagged and grown in continuous flow system in FAB medium supplemented with 0.3 mM glucose for 144 h.
Confocal images were acquired following 15, 24, 48, 96 and 144 h of growth.
doi:10.1371/journal.pone.0027842.g001
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(Figure 2) with enhanced morphotypical diversification in flow-
chamber biofilm populations (Table 1 and Figures 3 and 4). One
possible explanation is that mutators may provide the biofilm
community with a larger proportion of adapted mutants, which
can be enriched by selection for better growth in the biofilm
environment. It is therefore possible that mutator strains have a
competitive advantage over wild-type populations during biofilm
development. In an attempt to probe this possibility and to
investigate the role of hypermutability on the evolution of P.
aeruginosa biofilms, we performed competition experiments be-
tween mutator and wild-type strains. For this purpose, flow-cell
chambers were co-inoculated with a 1:1 initial ratio of differen-
tially YFP-tagged wild-type and CFP-tagged mutator cells, and the
spatial distribution of the bacteria was recorded as the biofilm
developed (Figure 5). After 48 h of incubation, separated yellow
and blue micro-colonies were observed in the mixed biofilms
(Figure 5), revealing a clonal origin of micro-colonies as previously
documented [32]. However, in 4-day-old biofilms the mutators
became dominant occupying almost the entire biofilm at day 6
(Figure 5 B, C and I, J). At this time, the biofilms were harvested
and plated on LB-agar in order to determine the actual sub-
population sizes. Consistent with the microscopic observations the
mutator cells outnumbered the wild-type cells by a factor of 5.5 for
Hex1T and 6.3 for PAO1. In addition, planktonic growth
competition assays were performed in liquid aerated media by
co-inoculating with 1:1 initial ratio of wild-type and mutator
strains. Interestingly, Hex1TMS:Hex1T and PAOMS:PAO1 final
ratios of 0.11 and 0.56, respectively, were obtained after six days of
growth in FAB media, showing that the increased competiveness
of the mutators was specific for the biofilm mode of growth.
Based on this observation, we next investigated if the mutator
biofilm advantage was also observed in asymmetric competition
experiments, where their initial proportion was significantly lower
than those of wild-types. For this purpose, mixed biofilms with a
1:0.01 initial ratio of wild-type and mutS mutant strains were
investigated. As shown in Figure 5, large clusters of wild-type cells
still comprised the majority of the biofilms after 96 h of
incubation, but after that time point, mutators became more
and more dominant, clearly outcompeting the wild-type at 192 h
(Figure 5 D-G and K-N), confirming the mutator advantage over
wild-type when growing as biofilms.
It is important to note that generation times in liquid media of
the Hex1TMS and PAOMS mutants and their wild-type
counterparts were identical (not shown), and opposite fluorescence
tagging combinations produced the same results (not shown).
Evidence for adaptive evolution in mutator biofilms
In order to examine whether the increased competiveness of the
mutator strains in biofilms is related to their increased rates of
Figure 2. P. aeruginosa mutators biofilms display increased
microcolony diameter sizes. (A) The dynamics of microcolony
diameters for Hex1T (filled circles) and Hex1TMS (open circles) strains is
shown. Values represent means 6 standard error of 24 random chosen
CLSM images for each strain and time point. All differences were tested
for statistic significance using the ANOVA with repeated measures test
(P,0.05). (B) Equivalent results were obtained when microcolony
diameter sizes were compared between biofilms formed by the wild-
type PAO1 (filled circles) and the mutator PAOMS (open circles) strains.
doi:10.1371/journal.pone.0027842.g002
Figure 3. Hypermutability due to mutS deficiency increases morphotypic diversification in continuous flow-cell biofilms. Colony
morphologies of morphotypic variants isolated from P. aeruginosa mutator bioflms. (A) Normal; (B) Small; (C) Translucent; (D) Wrinkled; (E) Mucoid-
like; (F) Undulate; (G) Large; (H) Filiform; (I) Hyper-pigmented. Bars indicate 1 cm.
doi:10.1371/journal.pone.0027842.g003
Mutators and Biofilm Development in P. aeruginosa
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diversification, we chose the most abundant morpho-variants (T,
W, S and L now named Hex1TMS-T, W, S and L respectively)
obtained from Hex1TMS biofilms, and investigated their compe-
tiveness in biofilms inoculated with a 1:1 ratio of each of these
CFP- tagged variants and the YFP-tagged Hex1TMS parental
clone (now named Hex1TMS-P). At 24 h of incubation the
variant Hex1TMS-T was present as isolated and small clusters of
cells, and the number of Hex1TMS-P and Hex1TMS-T cells was
roughly the same (Figure 6 A). In contrast, at the same stage of
biofilm development the variants Hex1TMS-W, S and L showed
significantly enhanced micro-colony development with cell clusters
that reached a more advanced maturation level (Figure 6 D, G
and J). At 48 h all variants tested outcompeted the Hex1TMS-P
strain and constituted the majority of the biofilms after 96 h of
incubation (Figure 6). Importantly, biofilms formed by each
variant displayed a particular architecture that was structurally
different from that of Hex1TMS-P: (i) Hex1TMS-T formed
thinner biofilms with micro-colonies that mostly did not reach
20 mm in height, but which covered the whole surface with a
compact carpet of cells (Figure 6 C); (ii) Hex1TMS-S formed
typical mature mushroom-shaped micro-colonies more than
20 mm in height although biofilms displayed a poorer surface
area coverage (Figure 6 I); (iii) Hex1TMS-L and Hex1TMS-W
formed hyper biofilms with the tallest mushroom-shaped struc-
tures (Figure 6 F and L).
These results suggest that the distinct morphotypes tested here
may have specialized biofilm functions, which provide them with
competitive advantages during biofilm development.
Discussion
In this communication we have investigated the combined roles
of biofilm growth and increased mutations rates with respect to a
possible reproduction of some of the adaptive processes and
outcomes in CF airways, when performed in in vitro flow-cell
biofilm set-ups. One of the interesting questions is whether biofilm
development and occurrence of mutator variants are somehow
linked, and if the two create especially favorable conditions for the
establishment of chronic infections based on highly adapted
variants. The presented observations of P. aeruginosa flow-cells
biofilms were then directed towards a clarification of the
relationship between the biofilm life-style and the consequences
of increased mutation rates in bacterial biofilm populations. The
impacts of increased mutation rates, caused by knock-out
mutations in the MRS associated gene, mutS, were analyzed for
two different strains of P. aeruginosa. Once micro-colonies had been
established, mutator biofilms showed an accelerated and enhanced
growth, and developed some micro-colonies with larger diameters
producing a structural heterogeneity of the entire biofilm
(Figure 2). Micro-colonies constitute the basic structural unit in
many sessile communities, and as discrete foci of proliferation they
may also represent important sites for mutation and evolution
within biofilms [50]. Previous studies report that biofilm
communities of P. aeruginosa show up to 100-fold increased
mutation rates compared to planktonic cultures [52], and that
such high rates are associated particularly with cells localized in
micro-colonies [50]. Our results support these observations,
demonstrating that high mutation rates lead to larger and more
heterogeneous micro-colony structures, underlining the impor-
tance of mutations and genetic rearrangements as determinants of
micro-colony based growth and ultimately biofilm architecture.
In many studied cases biofilm growth has been shown to result
in phenotypic diversification for several bacterial species including
P. aeruginosa [30,44,46,47,51,63]. Here, we show that increased
mutation rates caused by MRS deficiency further resulted in
increased diversification in P. aeruginosa mutator biofilms in
comparison to isogenic wild-type biofilms (Table 1, Figures 3
and 4). Generation of genetic diversity in biofilms communities has
been associated with the seeding dispersal process [57], an active
selective cell lysis mechanism that would confer a population
survival advantage during further colonization. It was found here
that the rates of loss of biomass from the central parts of micro-
colonies in mutator biofilms were also increased in comparison
with their non-mutator counterparts (Figure S2 B), observations
that may be directly related to the higher degree of phenotypic
variation in mutator biofilms. Therefore, our results strongly
suggest a role for mutagenesis in determining micro-colony growth
and biofilm architecture, but also in favoring seeding dispersal and
phenotypic diversification.
A central finding from our work is that P. aeruginosa MRS-
deficient mutator strains effectively outcompeted wild-type bacte-
ria in mixed biofilms (Figure 5) but not in planktonic growth. In E.
coli populations undergoing adaptation, mutators spontaneously
occurring as a consequence of mutations in DNA repair genes can
be enriched and become dominant in the population through their
co-selection with advantageous mutations (hitch-hiking) [3,65,66].
Moreover, it has been experimentally proven that overcoming
successive selection barriers results in a great amplification of
mutator cells in E. coli populations [65,67] and that, when facing
new environments or stressful conditions, mutator phenotypes can
speed up adaptation of a bacterial population through increased
generation of useful variants [68]. Such is the case of antibiotic
resistant variants, shown to drive the amplification of mutator
populations under antibiotic exposure in several models, recently
including biofilm growth [69]. However, in this work we had the
possibility to follow in situ how the adaptive advantage of mutator
cells is associated with greater rates of diversification during
biofilm development. It is important to note that although the
Table 1. Frequency of occurrence of morphotypic variants from 144 h-old biofilms of Hex1T, Hex1TMS, PAO1 and PAOMS.
Variants (%)
Normal (N) Small (S) Translucent (T) Wrinkled (W) Mucoid (M) Large (L) Undulate (U) Filamentous (F)
Hyper-
pigmentated (H)
Hex1T 98.48 0.02 1.48 0 0.01 0 0.01 0 0
Hex1TMS 77.88 0.59 16.75 3.12 0.04 1.40 0.12 0.08 0.02
PAO1 99.77 0.13 0.10 0 0 0 0 0 0
PAOMS 63.92 5.45 14.95 0.19 0.19 15 0.30 0 0
Values are expressed as percentage of the 104 CFU screened.
doi:10.1371/journal.pone.0027842.t001
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experiments reported here were short-term they were carried out
in the absence of any exogenous selective pressure (such as
addition of antibiotics to the culture media), and that in
homogenous planktonic growth competitions experiments the
mutS mutator strains were not favored. Thus, our results suggest
that the specific selective forces governing growth in the
heterogeneous biofilm environment drive the competitive advan-
tage of P. aeruginosa mutator clones. The observation that distinct
and different variants isolated from mutator biofilms (Figure 3;
Figure S3) were able to outcompete the mutator parental strain in
a second round of flow-cell biofilm cultures (Figure 6) suggests that
these variants may have acquired different adaptive mutations that
provide a competitive advantage to the biofilm mode of growth.
Thus, mutator advantage over wild type when grown in biofilms
appears to be associated with greater rate of diversification.
It has been shown that in P. aeruginosa biofilms the seeding
dispersal [56] and phenotypic variation can be induced by
oxidative stress [51], evidenced by the fact that phenotypic
diversification in biofilms was inhibited by the addition of
antioxidant compounds [51]. In accordance with this, it has also
been reported that synthesis of antioxidant enzymes is down-
regulated in P. aeruginosa biofilms, which may enhance the
occurrence of mutagenic events due to accumulation of DNA
oxidative damage events [52]. It has been further shown that
oxidative stress induced mutagenesis most likely is based on RecA
dependent recombination repair mechanisms, but not on MRS or
Pol IV error prone DNA polymerase [51]. Thus, even in biofilms
consisting of only wild-type cells, oxidative stress-induced muta-
genesis can lead to diversification of the biofilm population.
However, for P. aeruginosa MRS-deficient strains, the mutagenic
mechanisms involved in biofilm-associated phenotypic diversifica-
tion may not be exclusively related to oxidative stress, but to
alternative pathways. This observation would imply that in MRS-
deficient cells the evolutionary mechanisms allowing adaptation to
a sessile environment not only produce a comparatively enhanced
(quantitative) adaptation, but also use distinct (qualitative)
mechanistic pathways. In fact, based on the postreplicative action
and mismatch affinity of MutS, MRS deficiency may determine an
increased mutability biased towards a specific spectrum of
mutations [8], or only at some loci [9]. Moreover, mechanisms
that lead to an increased genetic/phenotypic variation could well
include phase variation, adaptive mutations, genetic rearrange-
ments, enhanced transfer through conjugation, and transforma-
tion mechanisms which have been documented to be activated in
MRS deficient cells [7,8,10,59,70,71]
It is likely that these mutagenic processes also take place in CF
airways, exposing the P. aeruginosa population to mutagenic factors
no matter if the bacteria live as planktonic cells in the mucus, as
biofilms encased in alginate or in any other state, and the
increased mutation rates most likely offer excellent possibilities for
accumulation of fitness increasing mutations if the population size
is big enough. Translating the present results obtained from flow-
cell biofilms into relevant suggestions for the adaptive processes
which P. aeruginosa undergoes during its infection cycle in CF
patient airways, we can now hypothesize that the occurrence of
mutator cells in the P. aeruginosa airway biofilm population may
lead to a subsequent dominance of the mutators due to the
efficient biofilm associated out-competition of non-mutators. The
consequence is population diversification as it has been observed
for many CF patients. Variants with increased capacity to form
biofilm in the airway environment will be expected to appear in
the population. This hypothesis explains the links between three
important aspects of P. aeruginosa adaptation in CF airways: the
biofilm state of growth, the fixation and dominance in many
Figure 4. Diversity shown by P. aeruginosa mutator strains is
intrinsic of flow-cell biofilm mode of growth. The diversity index
Shannon-Weaver H was calculated for non-mutator strains Hex1T (A,
black bars) and PAO1 (B, black bars) and for mutator strains Hex1TMS
(A, gray bars) and PAOMS (B, gray bars) in the inocula from which
biofilms were initiated; in 6-day-old flow-chambers biofilms and in
planktonic subcultures grown for 6 days with constant agitation. (C)
Diversity was also analyzed in the effluents from Hex1T (filled circles)
and Hex1TMS biofilms (open circles) at 48, 96 and 144 h of biofilm
growth. All values represent means 6 SD of three experiments
performed by triplicate. The differences were analyzed for statistical
significance using the Student t test.
doi:10.1371/journal.pone.0027842.g004
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patients of mutators, and the generation of diversity in the
bacterial population.
Materials and Methods
Bacterial strains and growth conditions
P. aeruginosa reference strain PAO1 [53] and the environmental
strain Hex1T [54], originally isolated from hydrocarbon-contam-
inated soil, were used. Isogenic PAO1 and Hex1T mutS mutants
[6,55] were used in the present study and referred as PAOMS and
Hex1TMS, respectively. Strains were stored at 270uC in 30% (v/
v) glycerol and subcultured from storage onto Luria Bertani (LB)
medium. P. aeruginosa PAO1 strains were fluorescently tagged at
the att intergenic neutral chromosomal locus with gfp, cfp or yfp
with miniTn7 constructs as previously described [31]. Hex1T
strains were electroporated with pJBA128 [72], pJB1197 and
pJB1199 plasmids carrying GFP, YFP and CGP fluorescent
proteins, respectively. Modified FAB medium [73] supplemented
with 0.3 mM glucose was used for biofilm cultivation. Biofilms and
batch cultures were grown at 30uC. Antibiotics were used at the
following concentrations: 30 mg/ml gentamicin (Gm); 250 mg/ml
kanamycin (Km); 200 mg/ml streptomycin (Sm); 60 mg/ml tetra-
cicline.
Flow-cell biofilm experiments
Biofilms were grown at 30uC in flow chambers with individual
channel dimensions of 164640 mm. The flow system was
assembled and prepared as described previously [74]. Each
biofilm experiment was conducted by using frozen cells as the
starting stock. In order to ensure that attachment mediated by type
IV pili and subsequent structured biofilm formation were not
affected [31,75], before each biofilm culture, twitching motility
assays were routinely performed as previously described [43]. A
twitching positive colony from a plate was used to inoculate test
tubes containing LB media and grown at 30uC for 16 h with
aeration. Cultures were diluted to an OD600 of 0.001 in 0.9%
NaCl and used for inoculation; 250 ml were injected with a small
syringe. After inoculation flow channels were left without flow for
1 h to allow bacterial adherence, after which medium flow
(0.2 mm/s) was started using a Watson Marlow 205S peristaltic
pump.
For the analysis of the structure and evolution of P. aeruginosa
PAO1, Hex1T, PAOMS and Hex1TMS biofilms, three indepen-
dent biofilm experiments were performed. In every round, each
strain was grown by triplicate, running three separate channels,
and from each channel four image stacks were acquired at
different time point (15, 24, 48, 96 and 144 h after inoculation).
Thus, 36 image stacks were analyzed for each strain at each time
point. In all the experiments, images were acquired from random
positions in the upper part of the flow channel, at a distance of 5–
10 mm from the inlet.
Microscopy and image analysis
All microscopic observations were performed on a Zeiss
LSM510 confocal laser scanning microscope (CLSM) (Carl Zeiss,
Jena, Germany) equipped with an argon laser, detector and filter
Figure 5. P. aeruginosa mutator strains show a greater adaptability to biofilm growth in flow chambers. Biofilm competition
experiments between Hex1T:Hex1TMS (A-G) and PAO1:PAOMS (H-N) were initiated with a 1:1 and 1:0.01 mixtures of yellow fluorescent non-mutator
and cyan fluorescent mutator bacteria and grown in FAB glucose media. The structural development in the biofilm was followed by CLSM for 144 and
196 h for 1:1 and 1:0.01 competition ratios, respectively. The images shown are representative 3D-IMARIS shadow projection micrographs.
doi:10.1371/journal.pone.0027842.g005
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sets for monitoring of gfp, cfp and yfp expression. Images were
obtained by using a 406/1.3 Plan-Neofluar oil objective and were
processed using the COMSTAT image analysis program [76].
Simulated three-dimensional images and sections were generated
by using the IMARIS software package (Bitplane AG, Zurich,
Switzerland).
Phenotypic diversification experiments
i. Biofilms. To study phenotypic diversification, at 144 h of
growth biofilms were harvested and adequate dilutions were plated
on LB agar and incubated for 48 h at 37uC. Morphology of
approximately 104 colonies per strain from three independent
experiments was examined by visual inspection.
Diversity from the biofilm effluents was monitored at 48, 96 and
144 h, by collecting into sterile tubes 1 ml of effluent media of P.
aeruginosa Hex1T and Hex1TMS strains. Serial dilutions of each
effluent were plated on LB agar and examined for morphotypic
colony variants (at least 104 colonies). Morphotypic colony
diversification in the inocula was tested by direct plating of part
of bacterial cultures used to establish biofilms.
ii. Liquid culture. To test. morphotypic colony
diversification in planktonic cultures, bacteria (107 cells/ml) were
incubated aerobically in FAB medium (10 ml, 30 mM glucose) at
30uC for 24 h, diluted 1/100 into fresh FAB and incubated again
for 24 h. This cycle was repeated for four times. On sixth day,
serial dilutions were plated on LB agar and incubated at 37uC for
48 h. Morphology of approximately 104 colonies per strain from
three independent experiments was examined by visual inspection.
Diversity
Diversity (H) was calculated using the Shannon-Weaver index
[H= (N logN2Sn log ni)/N], where N is the total number of
individuals and ni is the number of individuals of each phenotype.
Competition experiments
i. Biofilms. Pairs of PAO1:PAOMS and Hex1T:Hex1TMS
strains differentially tagged with yellow (wild types) and cyan
(mutators) fluorescent proteins were co-cultured in flow cells and
dynamics of mixed biofilms was followed by CLSM. Initial ratios
were 1:1 and 1:0.01 and final ratios for 1:1 competitions were
tested at 144 h by harvesting biofilms and plating serial dilutions
on LB agar either containing 200 mg/ml of streptomycin or
30 mg/ml of gentamicin for selection PAO1 and PAOMS,
respectively, or containing 250 mg/ml of kanamycin for
Hex1TMS selection. Triplicate channels of each mixed culture
were examined in at least two independent experiments with an
additional run with the opposite color combination.
For competition experiments between colony morphology
variants and the ancestor Hex1TMS-P strain the four most
prevalent phenotypes (S, L, W and T), directly obtained from the
diversification analysis were resuspended in NaCl 0.9% and
inoculated in the mixed biofilm. Initial ratios were 1:1 ratio and
each colony morphology variant was tagged with the cfp gene
differently from the YFP-tagged Hex1TMS ancestor strain.
Triplicate channels of each strain pair were run in at least two
independent experiments.
ii. Liquid cultures. For competition assays in liquid aerated
media, pairs of PAO1:PAOMS and Hex1T:Hex1TMS strains
were co-cultured in 10 ml of FAB media supplemented with
30 mM glucose at a initial 1:1 ratio (approximately 107 cells/ml)
and incubated at 30uC for 24 h. Then 100 ml of a 1024 dilution of
these cultures were inoculated into fresh FAB and incubated again
for 24 h. This cycle was repeated four additional times and on the
sixth day, serial dilutions were plated on LB agar containing
200 mg/ml of streptomycin and LB-agar containing 30 mg/ml of
gentamicin for selection PAO1 and PAOMS, respectively, or
containing 250 mg/ml of kanamycin for Hex1TMS selection. The
plates were incubated at 37uC for 24 h. The experiment was
repeated four times.
Statistical analysis
Structural data were compared using a Student t test. In all
cases, P values of ,0.05 were considered statistically significant.
Analysis of variance [94] with repeated measures was used to
compare the differences in microcolony diameters assessing the
interaction between time (24, 48, 96 and 144 h) and strains using
SPSS Statistic Standard 15.0 software (IBM). Logarithmic
transformations were applied for all the data so that they met
with normal distribution and homogeneity of the variances. All
comparisons were determined after Bonferroni’s correction of P
values.
Supporting Information
Figure S1 Biofilm parameters analyzed by using COM-
STAT software. Biomass, maximum thickness and surface-to-
volume ratio were calculated at 15, 24, 48, 96 and 144 h after
inoculation in flow-cell biofilms formed by Hex1T and PAO1
Figure 6. Mutator variants are widely adapted to growth in
biofilm flow chambers. Biofilm competition experiments were
performed between the parental YFP-tagged Hex1TMS-P strain and
the four CFP-tagged mutator variants: translucent (Hex1TMS-T, A-C),
wrinkled (Hex1TMS-W, D-F), small (Hex1TMS-S, G-I) and large (Hex1TMS-
L, J-L). All mixed biofilms were initiated with a 1:1 mixture of
corresponding bacteria and biofilm development was followed by
short periods (96 h) by CLSM. Shown are representative 3D-IMARIS
shadow projection micrographs.
doi:10.1371/journal.pone.0027842.g006
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strains and their respective isogenic Hex1TMS and PAOMS
strains. COMSTAT was carried out from images acquired from
random positions in the inner part of the flow channel. The
asterisks indicate statistical differences (P,0.05) between mutator
(white bars) and wild-type (black bars) strains. Results represent the
mean 6 SEM of three independent experiments.
(TIF)
Figure S2 Seeding dispersal is highly frequent in P.
aeruginosa Hex1TMS biofilms. (A) Confocal micrograph
showing a P. aeruginosa Hex1TMS hollow microcolony. The image
was obtained 96 h after flow-cells were inoculated. Subpopulation
of swimming cells inside the microcolony can be visualized. (B)
Number of hollow microcolonies/cm2 in biofilms formed by
Hex1T (black bars) and Hex1TMS (grey bars). Quantification was
performed by assessing the number of void microcolonies in
16 mm2 flow-channel area for each strain at 48, 96 and 144 h of
biofilm incubation. The results are representative of measurements
of three experiments.
(TIF)
Figure S3 Characterization of colony morphology of P.
aeruginosa He1TMS variants obtained from mutator
biofilms. Overnight cultures (5 ml) of bacterial cultures were spot
on LB-agar plates supplemented with 40 mg/ml of Congo red dye
(A) or 4 mM FeSO4 (B) and incubated at 30uC for 48 h. Hex1T
wild-type and the parental Hex1TMS-P mutator strains showed
morphotypes typically redish (with concentrically colorless rings),
and brownish when plated on Congo red and on high iron media
respectively. All Hex1TMS-T, S, W and L morphotypic variants
displayed colorless colonies when plated on iron supplemented
media. On Congo red, colonies were shiny autolytic for
Hex1TMS-T; light pigmented with red edges for Hex1TMS-W;
and hyperpigmented for Hex1TMS S and L.
(TIF)
Table S1 Motility assays of P. aeruginosa Hex1MS-P parental
morphotype and Hex1MS-T, -W, -S and –L morphotypes biofilm
variants.
(DOC)
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